PACTR202001787519553招募中未知
ow dose aspirin for preventing intrauterine growth restriction and preeclampsia in sickle cell pregnancy (PIP-SICKLE): a randomised controlled trial.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- TETFUND
- 入组人数
- 476
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- Female
入选标准
- •Age 18 years and above
- •Singleton fetus
- •Women with sickle cell anaemia i.e. Haemoglobin SS.
- •16 weeks gestation or less at recruitment, confirmed by an ultrasound scan or certain last menstrual period dates
排除标准
- •Other sickle cell disease variants eg Hb SC
- •Women with associated medical conditions in pregnancy eg HIV infection, diabetes mellitus, chronic hypertension, renal disease, sickle nephropathy
- •Women with multiple pregnancy
- •Hypersensitivity to aspirin
- •History of vaso-occlusive crisis in the last 4 weeks
- •History of blood transfusion in the last 3 months
研究者
相似试验
已完成
不适用
Aspirin for prevention of adverse pregnancy outcome in women with elevated alfa-feto proteiElevated level of alfa fetoprotein in second trimester screening.IRCT201203018954N1Tehran University of Medical Sciences109
已完成
3 期
ow-dose aspirin in the prevention of preeclampsiaPreeclampsiaPregnancy and ChildbirthPre-eclampsiaISRCTN81414657Beacon Pharmaceuticals Ltd200
尚未招募
不适用
To study the role of low dose Aspirin in prevention of PreeclampsiaCTRI/2019/05/019232Vss Institute of medical science and research
已完成
2 期
Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of GestationPlacental InsufficiencyNCT01616615Sara Varea190
已完成
不适用
ow-dose aspirin for reduction in preeclampsia risk in high-risk women in Japan.preeclampsiaJPRN-UMIN000020013Osaka Medical Center and Research Institute for Maternal and Child Health600